Akzo Nobel India Limited
National Stock Exchange of IndiaTotal Valuation
Akzo Nobel India Limited carries a market capitalization of 136.02B, placing it among publicly traded companies globally. Its enterprise value stands at 155.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 136.02B |
| Enterprise Value | 155.55B |
Valuation Ratios
Akzo Nobel India Limited trades at a trailing price-to-earnings ratio of 38.32.
| PE Ratio | 38.32 |
| PS Ratio | 3.85 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Akzo Nobel India Limited trades at an EV/EBITDA multiple of 29.84 and an EV/FCF ratio of 2,062.15. The EV/Sales ratio of 3.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.84 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.85 |
| EV / EBITDA | 29.84 |
| EV / EBIT | 29.84 |
| EV / FCF | 2,062.15 |
Financial Position
Akzo Nobel India Limited maintains a current ratio of 2.78, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.19, indicating elevated leverage, while an interest coverage ratio of 52.12 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.78 |
| Quick Ratio | 0.60 |
| Debt / Equity | 9.19 |
| Debt / EBITDA | N/A |
| Interest Coverage | 52.12 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 448.04 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Akzo Nobel India Limited has paid 1.32B in income taxes, reflecting an effective tax rate of 24.57.
| Income Tax | 1.32B |
| Effective Tax Rate | 24.57 |
Stock Price Statistics
Akzo Nobel India Limited's stock has declined approximately -14.30047% over the past 52 weeks. The 50-day moving average sits at 2,941.41, while the 200-day moving average is 3,242.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.30047% |
| 50-Day Moving Average | 2,941.41 |
| 200-Day Moving Average | 3,242.05 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Akzo Nobel India Limited generated 40.42B in revenue and converted that into 4.06B in net income, yielding earnings per share of 89.12. EBITDA reached 5.21B, while operating income came in at 5.21B.
| Revenue | 40.42B |
| Gross Profit | 17.29B |
| Operating Income | 5.21B |
| Pretax Income | 5.38B |
| Net Income | 4.06B |
| EBITDA | 5.21B |
| EBIT | 5.21B |
| Earnings Per Share (EPS) | 89.12 |
Margins
Akzo Nobel India Limited operates with a gross margin of 42.78, reflecting its pricing power and cost economics. The operating margin of 12.89 and net profit margin of 10.04 provide insight into operational efficiency.
| Gross Margin | 42.78 |
| Operating Margin | 12.89 |
| Pretax Margin | 13.31 |
| Profit Margin | 10.04 |
| EBITDA Margin | 12.89 |
Scores
Akzo Nobel India Limited posts an Altman Z-Score of 16.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.78 |